Trade ELOX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Eloxx Pharmaceuticals, Inc. (ELOX) is trading at US$15.00, up 5.71% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$72.08M. Over the past 52 weeks, ELOX has traded between US$0.00 and US$23.40. On Syfe you can trade ELOX with $0 commission and add it to your watchlist.
| Previous close | US$14.19 |
|---|---|
| Market cap | US$72.08M |
| 52-week range | US$0.00 – US$23.40 |
| Volume | 38.84K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.
Year: 1998
--Guggenheim Initiates Eloxx Pharmaceuticals at Buy With $43 Price Target
Jul 20, 10:52 AM · MT Newswires
Eloxx Pharmaceuticals, Inc. (ELOX) stock is trading at US$15.00, +5.71% from the previous close of US$14.19.
The market cap for Eloxx Pharmaceuticals, Inc. (ELOX) stock is approximately US$72.08M.
The 52-week high for Eloxx Pharmaceuticals, Inc. (ELOX) stock is US$23.40.
The 52-week low for Eloxx Pharmaceuticals, Inc. (ELOX) stock is US$0.00.
Eloxx Pharmaceuticals, Inc. (ELOX) does not currently pay a dividend.
Stay on top of ELOX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
